On November 19th, 2018, CQDM celebrated its 10th Anniversary with 300 people involved in the life sciences field, including members from the pharmaceutical industry, scientists from academic research institutions, entrepreneurs, partners and government representatives. During this event, Diane Gosselin, President and CEO of CQDM, unveils a study carried out over the last 10 years, revealing…
CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics The program will leverage AbCellera’s high-throughput, single-cell screening platform to allow rapid identification of functional antibodies against complex membrane proteins. MONTREAL, January 12th, 2018– CQDM and Brain Canada are proud to announce the non-dilutive…
Rémi Quirion appointed member of CQDM’s Board Montreal, November 28th, 2017 – The Chairman of CQDM’s Board, Richard Fajzel, and the President and CEO of CQDM, Diane Gosselin, are pleased to announce the appointment of Rémi Quirion, Chief Scientist of Quebec on the CQDM’s Board. Rémi Quirion became Quebec’s first Chief Scientist in 2011. He is…
The CQDM is expanding its financing activities in all fields of biopharmaceutical research in Quebec Montréal, May 23 2017 – The CQDM is proud to be launching its new SynergiQc program, designed to stimulate industrial research in the biopharmaceutical field within academic settings and to create economic benefits for Quebec. SynergiQc aims to support Quebec companies, through the financing of academic research…
Summer Intership position – Administration and Accounting POSITION SUMMARY: The CQDM is looking for a student to assist the Vice President Finance and Administration with various administrative and accounting tasks. PRINCIPAL RESPONSIBILITIES: Bookkeeping; Assistance in the preparation of reports for the different levels of government (federal and provincial); Filing of documents; Assist with updating CQDM’s performance…
Montreal, March 24, 2017 – A project funded by CQDM and Brain Canada has resulted in the creation of NeuroCDRD, a new collaboration between the Centre for Drug Research and Development (CDRD), the Montreal Neurological Institute and Hospital at McGill University (MNI), and Merck. CQDM and Brain Canada, with financial support from Health Canada through the…
Position summary Under the authority of the Early Stage Clinical Trial (ESCT) Initiative’s Steering committee and in collaboration with the President and Chief Executive Officer of CQDM, the selected candidate will be responsible for the Initiative start-up, the elaboration and the implementation of the action plan for the Early Stage Clinical Trial (ESCT) Initiative. About…
DIRECTOR OF COMMUNICATIONS AND PUBLIC RELATIONS Position Summary Reporting to the President and Chief Executive Officer of CQDM, the Director will play a lead role in 3 key aspects of the organization: communications, public relations and government affairs. Furthermore, the selected candidate will be involved in other initiatives/consortium associated with CQDM or its partners. About…
Montreal, November 24, 2016 – Richard Fajzel, Chairman of the Board of Directors and Diane Gosselin, President and CEO of CQDM are very pleased to announce the appointment of two new members on the Board: Patrick Wier, Senior Vice President, In vitro/In vivo Translation Platform at GSK and Jorge Puente, co-founder and managing partner of Pleasanton Pharma Ventures.…
Montreal, September 19, 2016 – The Chairman of CQDM’s Board of Directors, Richard Fajzel and Diane Gosselin, President and CEO of CQDM are pleased to announce the appointment of Ali Tehrani, Co-founder, President and CEO of Zymeworks, and audacious entrepreneur, as new member of the Board. Ali Tehrani is well known in Canada and internationally for…